Symrise (FRA:SY1 – Get Rating) has been given a €130.00 ($139.78) price objective by research analysts at UBS Group in a report released on Thursday, Borsen Zeitung reports. UBS Group’s price target suggests a potential upside of 15.92% from the company’s current price.
A number of other analysts have also weighed in on SY1. Deutsche Bank Rese… set a €138.00 ($148.39) price objective on Symrise in a research report on Monday, March 28th. Berenberg Bank set a €119.00 ($127.96) price objective on Symrise in a research report on Thursday, March 24th. The Goldman Sachs Group set a €127.00 ($136.56) price objective on Symrise in a research report on Wednesday. JPMorgan Chase & Co. set a €115.00 ($123.66) price objective on Symrise in a research report on Wednesday. Finally, Deutsche Bank Aktiengesellschaft set a €138.00 ($148.39) price objective on Symrise in a research report on Wednesday, March 2nd. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, Symrise currently has a consensus rating of “Hold” and a consensus target price of €119.97 ($129.00).
Symrise stock opened at €112.15 ($120.59) on Thursday. Symrise has a twelve month low of €56.96 ($61.25) and a twelve month high of €73.48 ($79.01). The stock’s fifty day simple moving average is €106.45 and its 200-day simple moving average is €115.05.
Symrise AG supplies fragrances, flavorings, cosmetic active ingredients and raw materials, and functional ingredients. It operates through two segments, Taste, Nutrition & Health, and Scent & Care. The Taste, Nutrition & Health segment provides functional ingredients and flavor solutions used in the production of food and beverages; savory flavors; natural and sustainable ingredients for food and beverage manufacturers, baby food, and dietary supplements; product solutions and services for pet food manufacturers; sustainable ingredients and services for aqua feed manufacturers to develop solutions for fish and shrimp farms; and probiotics for food supplements and functional foods.
- Facebook (NASDAQ: FB) Soars And Wall Street Delights
- Automatic Data Processing Is Ready To Scale New Heights
- Carl Icahn Buys More Xerox
- Xerox Holdings Stock is a Value Play
- The Kraft Heinz Turnaround Story Gains Momentum
Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.